Funding available for NIH grant applications responding to presidentially declared disasters or public health emergencies through Emergency Notices of Special Interest.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.
This grant allows organizations with specific NIH grants to apply for a change of recipient status, called Successor-in-Interest; approval is not guaranteed.
NIH grant supports specific research projects aligned with NIH Institutes' missions, but excludes clinical trials.